Interference through shRNAs against CD63 causes redistribution of LMP1, leads to a dramatic increase in LMP1-induced NF-κB activity, and would benefit treatment of EBV infection (49). The gene discussed is PDLIM7; the disease is Epstein-Barr virus infection.